Login / Signup

COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays.

Heung-Sup SungKyoung Ho RohKi Ho HongMoon-Woo SeongNam Hee RyooHyun Soo KimJaehyeon LeeSo Yeon KimSook Won RyuMi Na KimMyung-Guk HanSang-Won LeeHyuk Min LeeCheon-Kwon Yoo
Published in: Annals of laboratory medicine (2020)
Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early detection of COVID-19 and immediate isolation of infected patients from the naive population are important to prevent further pandemic spread of the infection. Real-time reverse transcription (RT)-PCR to detect SARS-CoV-2 RNA is currently the most reliable diagnostic method for confirming COVID-19 worldwide. Guidelines for clinical laboratories on the COVID-19 diagnosis have been recently published by Korean Society for Laboratory Medicine and the Korea Centers for Disease Control and Prevention. However, these formal guidelines do not address common practical laboratory issues related to COVID-19 real-time RT-PCR testing and their solutions. Therefore, this guideline is intended as a practical and technical supplement to the "Guidelines for Laboratory Diagnosis of COVID-19 in Korea".
Keyphrases
  • sars cov
  • coronavirus disease
  • respiratory syndrome coronavirus
  • healthcare
  • emergency department
  • clinical practice
  • systematic review
  • public health
  • randomized controlled trial
  • mental health
  • transcription factor